Falls Among the Older Patients Treated for Cancer in Normandy's Outclinics: Screening and Prevention

Completed

• Conditions: Aged Patients Treated for Cancer in Outclinics
• Interventions: Diagnostic Test: screening risk for falling and identifiy the risk level low-intermediate-high; Diagnostic Test: 3 mnth-follow-up

• Registration Number: NCT06504628
• Lead Sponsor: University Hospital, Caen

Brief Summary

The French Plan National AntiChute (published on February 21, 2022) and international recommendations on falls prevention (Age Ageing,September 2022) recommend identifying the risk of falling in people aged 65 and over, at least once a year during a follow-up consultation. The presence of chronic illness such as cancer increases the risk for falling. Recommendations suggest targeted preventive interventions according to the risk level, and early reassessment at 3 months in case of high risk.

This study consists of a cross-sectional survey conducted during a week dedicated to patient safety (September 16-20, 2024), to identify the prevalence of patients at high risk for falling, requiring enhanced care. The relation between high risk for falling and social and oncological characteristics will be studied. A 3-month telephone follow-up will identify any obstacles to implementing the recommendations in this high-risk group.

This multicenter cross-sectional prospective study is exploratory.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2024-07-10
• Study First Submitted QC: 2024-07-10
• Study First Posted: 2024-07-17
• Status Verified: 2024-09
• Study Start: 2024-09-16
• Primary Completion: 2024-09-16
• Study Completion: 2025-02-15
• Last Update Submitted: 2025-03-24
• Last Update Posted: 2025-03-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 328

Inclusion Criteria

• aged 65 or over
• undergoing treatment for cancer or hematological malignancy (oral or injectable systemic treatment, radiotherapy)
• covered by health insurance
• having read the information document and no objection
• French-speaking
• Autonomous ( with occasional assistance with instrumental daily activities),

Exclusion Criteria

• refusal to participate
• unable to communicate
• dependent (requiring geriatric care)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
intermediate risk for fall subgroup	screening risk for falling and identifiy the risk level low-intermediate-high	according to Manuel Montero-Odasso M, Nathalie van der Velde, Finbarr C Martin, Mirko Petrovic, Maw Pin Tan, Jesper Ryg, et al. World guidelines for falls prevention and management for older adults: a global initiative. Age and Ageing, Volume 51, Issue 9, September 2022
high risk for fall subgroup	screening risk for falling and identifiy the risk level low-intermediate-high	according to Manuel Montero-Odasso M, Nathalie van der Velde, Finbarr C Martin, Mirko Petrovic, Maw Pin Tan, Jesper Ryg, et al. World guidelines for falls prevention and management for older adults: a global initiative. Age and Ageing, Volume 51, Issue 9, September 2022. Those patients will be contacted 3 mnths after inclusion for follow-up assessment
low risk for fall subgroup	screening risk for falling and identifiy the risk level low-intermediate-high	according to Manuel Montero-Odasso M, Nathalie van der Velde, Finbarr C Martin, Mirko Petrovic, Maw Pin Tan, Jesper Ryg, et al. World guidelines for falls prevention and management for older adults: a global initiative. Age and Ageing, Volume 51, Issue 9, September 2022
high risk for fall subgroup	3 mnth-follow-up	according to Manuel Montero-Odasso M, Nathalie van der Velde, Finbarr C Martin, Mirko Petrovic, Maw Pin Tan, Jesper Ryg, et al. World guidelines for falls prevention and management for older adults: a global initiative. Age and Ageing, Volume 51, Issue 9, September 2022. Those patients will be contacted 3 mnths after inclusion for follow-up assessment

Primary Outcome Measures

Name	Time	Method
prevalence of each of the three levels of fall-risk	Day 1	describe the distribution of patients in mild, intermediate and high risk for falling

Secondary Outcome Measures

Name	Time	Method
Describe the rate of high-risk patients who will have benefited from (full or partial) implementation of recommended interventions according to 3-month follow-up.	3 mnths
describe the Average number of STOPPFALL medications per patient. Rate of patients with at least one oncologydrug listed as a fall risk (CIPN), in the 3 fall risk categories	Day 1
look for association between high-risk categorization and rural place of residence, gender, age bracket (65-74 and 75 and over), investigating center, type of cancer (location).	Day 1
among high-risk patients followed up at 3 months, look for an association between the absence ofimplementation of recommendations and social, medical characteristics and motive	3 mnths

Trial Locations

Locations (10)

Hôpital Privé de l Estuaire; 🇫🇷 Le Havre, France

Centre Hospitalier Evreux-VErnon; 🇫🇷 Évreux, France

Caen UH; 🇫🇷 Caen, Normandie, France

Centre de radiothérapie de la Baie; 🇫🇷 Avranches, France

Centre de radiothérapie Maurice Tubiana/Polyclinique Parc; 🇫🇷 Caen, France

CLCC François Baclesse; 🇫🇷 Caen, France

Centre Hospitalier Public du Cotentin; 🇫🇷 Cherbourg, France

Centre Hospitalier Robert Bisson; 🇫🇷 Lisieux, France

Becquerel Cancer CEnter; 🇫🇷 Rouen, France

CHU de Rouen Charles Nicolle; 🇫🇷 Rouen, France